<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28255" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Reactive Arthritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cheeti</surname>
            <given-names>Apoorva</given-names>
          </name>
          <aff>University of New Mexico Health Sciences Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chakraborty</surname>
            <given-names>Rebanta K.</given-names>
          </name>
          <aff>Steward Medical\Good Samaritan Medical</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramphul</surname>
            <given-names>Kamleshun</given-names>
          </name>
          <aff>Shanghai Jiao Tong University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Apoorva Cheeti declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebanta Chakraborty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kamleshun Ramphul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28255.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Reactive arthritis (ReA) is inflammatory arthritis that manifests several days to weeks after a gastrointestinal or genitourinary infection. It is also described as a classic triad of arthritis, urethritis, and conjunctivitis. However, a majority of patients do not present with the classic triad. It was previously called "Reiter syndrome," and it was named after Hans Reiter, who first described this syndrome. It is believed that the disorder is due to an aberrant autoimmune response to a gastrointestinal or genitourinary infection caused by salmonella, shigella, campylobacter, or chlamydia. This activity describes the causes, pathophysiology, and presentation and highlights the interprofessional team's role in managing this disorder.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of reactive arthritis.</p></list-item><list-item><p>Assess&#x000a0;the presentation of a patient with reactive arthritis.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment and management options available for reactive arthritis.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care and outcomes in patients with reactive arthritis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28255">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28255.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Reactive arthritis (ReA) is inflammatory arthritis that manifests after several days to weeks after a gastrointestinal or genitourinary infection. It is also described as a classic triad of arthritis, urethritis, and conjunctivitis. However, a majority of patients do not present with the classic triad.&#x000a0;It was previously called&#x000a0;"Reiter syndrome," and it was named after Hans Reiter, who first described this syndrome. The name Reiter syndrome&#x000a0;was dismissed&#x000a0;because it&#x000a0;is believed&#x000a0;that&#x000a0;Hans Reiter was a member of The National Socialist German Workers' Party or the &#x0201c;Nazis&#x0201d; and the director of the&#x000a0;Kaiser Wilhelm Institute&#x000a0;of Experimental Therapy, under whose leadership the war prisoners were subject to many inhumane&#x000a0;experiments. Today,&#x000a0;it&#x000a0;is&#x000a0;believed&#x000a0;that&#x000a0;the disorder is&#x000a0;due to&#x000a0;an aberrant autoimmune response&#x000a0;to the gastrointestinal infection caused&#x000a0;by salmonella, shigella, campylobacter, or chlamydia.<xref ref-type="bibr" rid="article-28255.r1">[1]</xref><xref ref-type="bibr" rid="article-28255.r2">[2]</xref><xref ref-type="bibr" rid="article-28255.r3">[3]</xref></p>
      </sec>
      <sec id="article-28255.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Reactive arthritis is&#x000a0;known&#x000a0;to be&#x000a0;triggered by a bacterial infection, particularly of the genitourinary (Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma hominis, and Ureaplasma urealyticum) or gastrointestinal (GI) tract (<italic toggle="yes">Salmonella enteritidis</italic>, <italic toggle="yes">Shigella flexneri</italic>, and <italic toggle="yes">S. disenteriae</italic>, <italic toggle="yes">Yersinia enterocolitica</italic>, <italic toggle="yes">Campylobacter jejuni</italic>, <italic toggle="yes">Clostridium difficile</italic>). The incidence is about 2% to 4% after a urogenital infection, mainly with <italic toggle="yes">Chlamydia trachomatis,</italic> and varies from 0% to 15% after gastrointestinal infections with <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Shigella</italic>, <italic toggle="yes">Campylobacter</italic>, or <italic toggle="yes">Yersinia</italic>. This might be affected by the epidemiological and environmental factors, the pathogenicity of the bacteria, and differences in the study designs. The enteric ReA occurs commonly following enteric infections. However, chlamydia associated ReA is endemic, especially in developed countries.<xref ref-type="bibr" rid="article-28255.r4">[4]</xref><xref ref-type="bibr" rid="article-28255.r5">[5]</xref>&#x000a0;Rare cases have been reported after administering the Bacillus Calmette Guerin vaccine treatment for bladder cancer.<xref ref-type="bibr" rid="article-28255.r6">[6]</xref></p>
      </sec>
      <sec id="article-28255.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Reactive arthritis is relatively rare, and the incidence in population-based studies is reported to be 0.6 to 27 per 100,000. It is more common in adult males in the second and third decades of life.<xref ref-type="bibr" rid="article-28255.r7">[7]</xref>&#x000a0;About 1-3% of patients with nonspecific urethritis develop an arthritis episode. Overall, higher disease activity and worse functional capacity are seen in the lower socioeconomic populations.</p>
      </sec>
      <sec id="article-28255.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Reactive arthritis is an immune-mediated syndrome triggered by a recent infection. It is hypothesized that T lymphocytes are induced by bacterial fragments such as lipopolysaccharide and nucleic acids when invasive bacteria reach the systemic circulation. These activated cytotoxic-T cells attack the synovium and other self-antigens through molecular mimicry. The evidence of Chlamydia trachomatis and C pneumoniae ribosomal RNA transcripts, enteric bacterial DNA, and bacterial degradation products in the synovial tissue and fluid supports this. It is believed that&#x000a0;anti-bacterial cytokine response is also impaired in reactive arthritis, resulting in decreased bacteria elimination. It is, however, unclear why such localization of inflammation occurs. The prevalence of HLA-B27 in reactive arthritis is estimated at 30% to 50% in patients with reactive arthritis, although values range widely. In hospital-based studies with more severely affected patients, frequencies as high as 60% to 80% have been reported. HLA-B27 should not be used as a diagnostic tool for diagnosing acute ReA. The presence of HLA-B27 is believed to potentiate reactive arthritis by presenting bacterial antigens to T cells, altering the self-tolerance of the host immune system, increasing tumor necrosis factor-alpha production, promoting the invasion of microbes in the gut, and delaying clearance of causative organisms.<xref ref-type="bibr" rid="article-28255.r8">[8]</xref></p>
      </sec>
      <sec id="article-28255.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Initially, the dermal histopathological features of reactive arthritis are similar to psoriasis. Examination of the synovial fluid reveals large macrophages, reiter cells with phagocytosed neutrophils, lymphocytes, and plasma cells. Extensive pannus formation is very rare.</p>
      </sec>
      <sec id="article-28255.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>These symptoms manifest several days to weeks after the initial infection. Diarrhea or other symptoms caused by the offending agents are usually resolved when the patient develops arthritis. A detailed history and physical examination should be performed to investigate recent illnesses such as urethritis, diarrhea, etc. ReA can be self-limiting, recurrent, or continuous, and about 20% to 25% of the patients may progress to have chronic articular, ocular, and cardiac complications. For sexually acquired reactive arthritis, there is a history of sexual intercourse, usually with a new partner, within 3 months of arthritis symptoms. Genital symptoms precede arthritis by about 2 weeks on average. It may include dysuria, discharge, testicular pain in men, intermenstrual or postcoital bleeding, or deep pelvic pain apart from vaginal discharge in women.<xref ref-type="bibr" rid="article-28255.r9">[9]</xref>&#x000a0;Reactive arthritis is very common in HIV individuals, and hence, patients with the new-onset disease must have HIV ruled out. Individuals with HIV who develop reactive arthritis often develop severe psoriasiform dermatitis on the scalp, soles, palms, and flexures.</p>
        <p>
<bold>Physical Exam</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sausage-shaped finger, toe, or heel pain</p>
          </list-item>
          <list-item>
            <p>Asymmetric oligoarthritis- usually of the lower extremities</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis or iritis</p>
          </list-item>
          <list-item>
            <p>Acute diarrhea or cervicitis within 4 weeks of the onset of arthritis</p>
          </list-item>
          <list-item>
            <p>Urethritis or genital ulcers</p>
          </list-item>
        </list>
        <p>Two or more of the above features plus involvement of the skeletal system establishes the diagnosis.</p>
        <p>
<bold>Joint and entheses</bold>
</p>
        <p>Patients typically present with acute onset oligo-arthritis, mainly involving the lower extremities, sacroiliac joint, and the lumbar spine. Not more than 6 large joints are affected at a time, and the knee and ankle are the most commonly affected. Joint pain is classically nocturnal with early morning stiffness. Involvement is asymmetric and affects the weight-bearing joint. The joints are often warm, painful, and swollen. Tendinitis is a common feature of the disease. About 30% of patients suffer from associated enthesitis in the form of plantar fasciitis or Achilles tendinitis.<xref ref-type="bibr" rid="article-28255.r10">[10]</xref></p>
        <p>
<bold>Extra-articular manifestations&#x000a0;</bold>
</p>
        <p>Extra-articular manifestations&#x000a0;may involve the skeletal system (enthesitis, dactylitis), eye (conjunctivitis, anterior uveitis episcleritis, and keratitis), genitourinary (urethritis, cervicitis, prostatitis, salpingo-oophoritis, cystitis or circinate balanitis), mucosal and skin involvement (mucosal ulcers, keratoderma blennorrhagica and erythema nodosum), cardiac (carditis, aortic, conduction and valvular abnormalities), and nail changes (onycholysis, subungual keratosis, or nail pits) also are seen. Skin and mucocutaneous changes are common and may include hyperkeratotic skin and erythematous dermatitis. Nail dystrophy is common. Other involvements include pustular psoriasis on the sole (keratoderma menorrhagia), geographic tongue, circinate balanitis, or oral ulceration. Eye involvement is common and may include conjunctivitis (30%) or uveitis. In patients with visual symptoms, recognizing uveitis is paramount as it can rapidly lead to visual loss.&#x000a0;Rare cases can involve the cardiovascular system, causing conduction abnormalities in early-stage and aortic regurgitation when advanced. Myelopathy, as well as non-specific gastrointestinal features of diarrhea and colitis, can also persist.<xref ref-type="bibr" rid="article-28255.r11">[11]</xref></p>
      </sec>
      <sec id="article-28255.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Reactive Arthritis falls within the subclass of seronegative spondyloarthropathies that affect the axial skeleton. Other members of that group are Ankylosing spondylitis and Psoriatic arthritis. Joint involvement is oligoarticular and asymmetrical.&#x000a0;</p>
        <p>American College of Rheumatology developed diagnostic guidelines for Reactive arthritis in 1999. The criteria were divided into&#x000a0;</p>
        <p>
<bold>MAJOR</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Asymmetric oligo or monoarthritis involving lower extremities</p>
          </list-item>
          <list-item>
            <p>Either enteritis or urethritis symptoms preceding the onset of arthritis by a time interval of 3 days to 6 weeks</p>
          </list-item>
        </list>
        <p>
<bold>MINOR</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The presence of a triggering infection, as evidenced by culture positivity</p>
          </list-item>
          <list-item>
            <p>The presence of persistent synovial involvement</p>
          </list-item>
        </list>
        <p>Genitourinary symptoms, metatarsophalangeal joint involvement, elevated C reactive protein, and positive HLA- B27 render a 69% sensitivity and 93.5% specificity in diagnosing reactive arthritis.<xref ref-type="bibr" rid="article-28255.r12">[12]</xref>&#x000a0;Although reactive arthritis is a clinical diagnosis, laboratory tests to detect the offending pathogens to confirm concomitant or preceding infections are usually performed to support the diagnosis. Nucleic acid amplification tests&#x000a0;from&#x000a0;an early morning urine sample or urogenital swab are utilized to detect Chlamydia trachomatis and Neisseria gonorrhea. A nucleic acid amplification test for Mycoplasma genitalium is also available nowadays and is relevant in men with urethritis. Positive evidence of&#x000a0;<italic toggle="yes">Chlamydia</italic>&#x000a0;by polymerase chain reaction (PCR) in the joint is probably strongly diagnostic. However, the current methods used to detect chlamydia in the urine are not validated for diagnostic purposes for synovial samples. Serological testing for <italic toggle="yes">Chlamydia trachomatis</italic> is of limited importance due to serological cross-reactivity between&#x000a0;<italic toggle="yes">Chlamydia</italic><italic toggle="yes">&#x000a0;trachomatis</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Chlamydia</italic><italic toggle="yes">&#x000a0;pneumoniae</italic>, inability to distinguish past and present infection by the persistence of antibodies, lower or absent antibody response in lower urinary tract infections. Serological testing is available for <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Yersinia</italic>, and <italic toggle="yes">Campylobacter</italic> but is not useful&#x000a0;in clinical practice. There are also gastrointestinal infections,&#x000a0;such as&#x000a0;<italic toggle="yes">Shigella</italic>, for&#x000a0;which no reliable serological methods exist. A stool culture may help detect enteric pathogens.<xref ref-type="bibr" rid="article-28255.r13">[13]</xref><xref ref-type="bibr" rid="article-28255.r14">[14]</xref></p>
        <p>Certain complications, like uveitis, are important to identify. The slit-lamp exam helps diagnose cells in the anterior chamber in acute iritis. Therefore, ocular symptoms in a suspected patient should generate a prompt referral to an ophthalmologist. The usual presentation of uveitis involves acute pain, photophobia, visual impairment, scleral injection, and hypopyon.</p>
        <p>Acute phase reactants such as the erythrocyte sedimentation rate (ESR) or C-reactive protein may be elevated. Joint aspiration must be performed when possible to rule out other arthritis. Aspiration of the joint is often done to rule out septic arthritis and crystalline arthritis. The findings in synovial fluid are nonspecific and are characteristic of inflammatory arthritis, with elevated leukocyte counts (typically 2000 to 4000 WBC per ml), with neutrophil predominance. HLA B 27 can be measured as it correlates with the severity of the disease but is not diagnostic. It is also important in the localization of arthritis. Sacroiliitis occurs more commonly in&#x000a0;HLA B 27-positive patients&#x000a0;<xref ref-type="bibr" rid="article-28255.r15">[15]</xref>.&#x000a0;In a patient from an endemic population,&#x000a0;the tuberculin skin test should be performed. Plain radiographs may reveal nonspecific inflammatory joint findings in the acute phase. Ultrasonography or magnetic resonance imaging can diagnose peripheral synovitis, enthesitis, or sacroiliitis. Scintigraphy can reveal the early stages of enthesitis.</p>
      </sec>
      <sec id="article-28255.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>If an infectious agent has been identified as a trigger for reactive arthritis, antimicrobial therapy is recommended, often for 3 to 6 months. It can significantly shorten the time to remission.<xref ref-type="bibr" rid="article-28255.r16">[16]</xref>&#x000a0;Treatment of the underlying concomitant infection, if present, should be&#x000a0;initiated without delay. Patients who do not have an active infection do not benefit from antibiotic therapy.<xref ref-type="bibr" rid="article-28255.r17">[17]</xref> Vasey et al reported the results of a double-blinded prospective triple placebo trial in which <italic toggle="yes">Chlamydia</italic>-positive&#x000a0;patients by PCR were treated for 6 months with a combination of doxycycline and rifampin or azithromycin and rifampin. The treatment arm achieved statistically significant symptom remission and PCR negativity, although the study was underpowered to identify the preferred combination of antibiotics.&#x000a0;</p>
        <p>The goal of therapy in reactive arthritis is to provide symptomatic relief and prevent chronic complications. Non-steroidal anti-inflammatory drugs are the initial treatment of choice in the acute phase. Intra-articular or local glucocorticoids, as in cases of enthesitis or bursitis, can be used if the patient has mono/oligoarthritis. Mechanical devices like orthotics and insoles can be useful. Systemic use of glucocorticoids is limited to severe polyarthritis and cardiac and ocular manifestations. Disease-modifying antirheumatic drugs, mainly sulphasalazine, are effective in both acute and chronic ReA. Other agents, such as methotrexate and azathioprine, are useful in chronic arthritis. They are indicated in patients who have failed Nonsteroidal anti-inflammatory drug (NSAID) therapy. Biologicals such as tumor necrosis factor blocking agents (eg, infliximab and etanercept have been suggested in treating reactive arthritis. However, further studies are needed to determine their definitive indications.<xref ref-type="bibr" rid="article-28255.r18">[18]</xref><xref ref-type="bibr" rid="article-28255.r19">[19]</xref><xref ref-type="bibr" rid="article-28255.r20">[20]</xref>&#x000a0;All patients should be urged to become physically active. Strengthening exercises are a key component of long-term therapy to prevent muscle wasting.&#x000a0;</p>
      </sec>
      <sec id="article-28255.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The physician should be able to rule out conditions that present with similar clinical findings.&#x000a0;The most common differential diagnosis should include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gonococcal arthritis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Gouty arthritis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Still disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Septic arthritis</p>
          </list-item>
          <list-item>
            <p>Rheumatic fever&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Psoriatic arthritis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ankylosing spondylitis</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis</p>
          </list-item>
          <list-item>
            <p>Immunotherapy/immunization&#x02013;related arthropathy</p>
          </list-item>
          <list-item>
            <p>Secondary syphilis</p>
          </list-item>
          <list-item>
            <p>Tubercular arthritis&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28255.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Reactive arthritis usually has a self-limited course, and the symptoms resolve within 3&#x000a0;to 5 months. Symptoms lasting beyond 6 months indicate a chronic element of the disease. Sacroiliitis is the most common chronic joint involvement. Patients who are HLA-B27 positive have a higher risk of recurrence of ReA. 15-30% of patients with ReA can develop long-term arthritis or other joint abnormalities. The presence of hip involvement, unresponsiveness to NSAIDs, and ESR greater than 30 portend a worse outcome.</p>
      </sec>
      <sec id="article-28255.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of ReA include:&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Recurrent arthritis (15&#x000a0;to 50%)&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic arthritis or sacroiliitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ankylosing spondylitis (30&#x000a0;to 50% if the patient is also HLA-B27&#x02013;positive)&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Urethral stricture</p>
          </list-item>
          <list-item>
            <p>Aortic root necrosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cataracts&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cystoid macular edema</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28255.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The patient is advised to have regular follow-ups with his primary physician and the orthopedic physician to assess for any damage caused by the infection.</p>
      </sec>
      <sec id="article-28255.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The social taboo associated with genitourinary symptoms is often a barrier when obtaining a complete and accurate history from patients. Some studies have suggested that appropriate treatment of acute Genitourinary infection with a 3-month course of antibiotics can prevent ReA. However, this is highly controversial. Similarly, from a physician's perspective, identifying the triad of visual, genitourinary, and arthritis symptoms to a pattern of unifying diagnosis is time-sensitive. It is even more so when acute uveitis or iritis sets in, as they can rapidly progress to permanent loss of visual function if not intervened in due time.&#x000a0;</p>
      </sec>
      <sec id="article-28255.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Reactive arthritis is a multiorgan disorder best managed by a team of healthcare professionals, including a rheumatologist, ophthalmologist, gastroenterologist, physical therapist, nurse, and pharmacist. While evaluating, general physicians should not shy away from exploring the detailed history of sexual contact and genital symptoms.&#x000a0;There is no cure for reactive arthritis, and the treatment is supportive. All patients should be encouraged to become physically active, and a physical therapy consult should be obtained. The pharmacist should educate the patient on the types of drugs used, their benefits, and their side effects. If patients are prescribed steroids, the side effects must be closely monitored, and the drugs tapered as soon as the clinical symptoms subside. A consult with a dermatologist is recommended to assess skin lesions and recommend treatment. The key feature is patient education to help improve physical conditioning, function, and quality of life. The patient should exercise regularly to improve endurance and prevent joint stiffness. Also, the nurse practitioner should educate the patient about safe sex practices to prevent STDs. Because the disorder can induce anxiety and depression, a mental health nurse should follow these patients and offer counsel. Finally, all patients with reactive arthritis should follow up with an ophthalmologist since they remain at high risk for visual problems.<xref ref-type="bibr" rid="article-28255.r21">[21]</xref><xref ref-type="bibr" rid="article-28255.r22">[22]</xref></p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The progression of reactive arthritis is variable, but in most people, the disorder is self-limited, with the&#x000a0;resolution of the symptoms occurring by 6&#x000a0;to 18 months. Mortality is very rare today and is usually due to the treatments. In general, causes related to sexually transmitted infections have a worse outcome than those caused by gastrointestinal infections. Despite a cure, recurrences occur in 25&#x000a0;to 50% of cases, especially those who are HLA-B27 positive. Reactivation&#x000a0;may signal a new infection or stress. About 20% of patients have a long-term disease that results in enthesitis and destructive arthritis. Elevation of ESR, lack of response to NSAIDs, and hip joint involvement usually indicate poor outcomes.<xref ref-type="bibr" rid="article-28255.r23">[23]</xref><xref ref-type="bibr" rid="article-28255.r24">[24]</xref></p>
      </sec>
      <sec id="article-28255.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28255">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/arthritis/reactive-arthritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28255">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28255/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28255">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28255.s17">
        <title>References</title>
        <ref id="article-28255.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ar&#x000e9;valo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gratac&#x000f3;s Masmitj&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calvet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Orellana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carreto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Larrosa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Collantes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>P</given-names>
              </name>
              <collab>REGISPONSER group</collab>
            </person-group>
            <article-title>Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2018</year>
            <month>Oct</month>
            <day>03</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>221</fpage>
            <pub-id pub-id-type="pmid">30285828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picchianti-Diamanti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Panebianco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Salemi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sorgi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Di Rosa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tropea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sgrulletti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salerno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Terracciano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Amelio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lagan&#x000e0;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pazienza</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Sep</month>
            <day>27</day>
            <volume>19</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">30261687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Houzou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fianyo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kakpovi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koffi-Tessio</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Tagbor</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Oniankitan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mijiyawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Panorama of inflammatory arthropathies in rheumatologic consultations in Northern Togo.</article-title>
            <source>Med Sante Trop</source>
            <year>2018</year>
            <month>Aug</month>
            <day>01</day>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>320</fpage>
            <page-range>320-323</page-range>
            <pub-id pub-id-type="pmid">30270840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Generali</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bose</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Selmi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Voncken</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Damoiseaux</surname>
                <given-names>JGMC</given-names>
              </name>
            </person-group>
            <article-title>Nature versus nurture in the spectrum of rheumatic diseases: Classification of spondyloarthritis as autoimmune or autoinflammatory.</article-title>
            <source>Autoimmun Rev</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>935</fpage>
            <page-range>935-941</page-range>
            <pub-id pub-id-type="pmid">30005857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spyridakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Schriver</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grundmeier</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Porsch</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>St Geme</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Downes</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features and Outcomes of Children with Culture-Negative Septic Arthritis.</article-title>
            <source>J Pediatric Infect Dis Soc</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-234</page-range>
            <pub-id pub-id-type="pmid">29718310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Klausmeier</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Orr</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Reactive arthritis: a review.</article-title>
            <source>J Adolesc Health</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>309</fpage>
            <page-range>309-15</page-range>
            <pub-id pub-id-type="pmid">19306788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muilu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rantalaiho</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kautiainen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Virta</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Eriksson</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Puolakka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium.</article-title>
            <source>Clin Rheumatol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>555</fpage>
            <page-range>555-562</page-range>
            <pub-id pub-id-type="pmid">30259249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Protopopov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sieper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haibel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Listing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rudwaleit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poddubnyy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2017</year>
            <month>Oct</month>
            <day>24</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>240</fpage>
            <pub-id pub-id-type="pmid">29065931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Flew</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sexually acquired reactive arthritis.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-6</page-range>
            <pub-id pub-id-type="pmid">27037393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stavropoulos</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Soura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kanelleas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katsambas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antoniou</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Reactive arthritis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>415</fpage>
            <page-range>415-24</page-range>
            <pub-id pub-id-type="pmid">25199646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Reiter's syndrome: the classic triad and more.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-21</page-range>
            <pub-id pub-id-type="pmid">18436339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Selmi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gershwin</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and classification of reactive arthritis.</article-title>
            <source>Autoimmun Rev</source>
            <year>2014</year>
            <season>Apr-May</season>
            <volume>13</volume>
            <issue>4-5</issue>
            <fpage>546</fpage>
            <page-range>546-9</page-range>
            <pub-id pub-id-type="pmid">24418301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shohat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goswami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fillingham</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Della Valle</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Higuera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parvizi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing Periprosthetic Joint Infection in Inflammatory Arthritis: Assumption Is the Enemy of True Understanding.</article-title>
            <source>J Arthroplasty</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>3561</fpage>
            <page-range>3561-3566</page-range>
            <pub-id pub-id-type="pmid">30100134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pavic</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sebak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manolios</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Acute arthritis: predictive factors and current practice in the approach to diagnosis and management across two hospitals in Sydney.</article-title>
            <source>Intern Med J</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>1087</fpage>
            <page-range>1087-1095</page-range>
            <pub-id pub-id-type="pmid">29756282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>The pathogenesis of HLA-B27 arthritis: role of HLA-B27 in bacterial defense.</article-title>
            <source>Am J Med Sci</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>316</volume>
            <issue>4</issue>
            <fpage>257</fpage>
            <page-range>257-63</page-range>
            <pub-id pub-id-type="pmid">9766487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bojovi&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Streli&#x00107;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pavlica</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Reiter's syndrome--disease of young men-- analysis of 312 patients.</article-title>
            <source>Med Pregl</source>
            <year>2014</year>
            <season>Jul-Aug</season>
            <volume>67</volume>
            <issue>7-8</issue>
            <fpage>222</fpage>
            <page-range>222-30</page-range>
            <pub-id pub-id-type="pmid">25151762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carter</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Sneed</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Ricca</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Vasey</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Valeriano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stanich</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Oszust</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gerard</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.</article-title>
            <source>Arthritis Rheum</source>
            <year>2010</year>
            <month>May</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>1298</fpage>
            <page-range>1298-307</page-range>
            <pub-id pub-id-type="pmid">20155838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glintborg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lindstr&#x000f6;m</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Aaltonen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kristianslund</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Gudbjornsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chatzidionysiou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Askling</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nordstr&#x000f6;m</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hetland</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Di Giuseppe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dreyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kristensen</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>J&#x000f8;rgensen</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Eklund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grondal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ernestam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joensuu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>T&#x000f6;rm&#x000e4;nen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skydsgaard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hagfors</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kvien</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Lie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fagerli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geirsson</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Jonsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Provan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Krogh</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Jacobsson</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.</article-title>
            <source>Scand J Rheumatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>465</fpage>
            <page-range>465-474</page-range>
            <pub-id pub-id-type="pmid">30070923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhutia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kundal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kishore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Juneja</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Atypical Articular Presentations in Indian Children With Rheumatic Fever.</article-title>
            <source>Heart Lung Circ</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-204</page-range>
            <pub-id pub-id-type="pmid">28528779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sieper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Grootscholten</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van den Broek</surname>
                <given-names>RWM</given-names>
              </name>
              <name>
                <surname>Kachroo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>746</fpage>
            <page-range>746-753</page-range>
            <pub-id pub-id-type="pmid">27855973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maravic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozonnat</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Sevezan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gasqueres</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pastor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>P&#x000e9;r&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neil</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roch-Bras</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Daures</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sany</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Preliminary evaluation of medical outcomes (including quality of life) and costs in incident RA cases receiving hospital-based multidisciplinary management.</article-title>
            <source>Joint Bone Spine</source>
            <year>2000</year>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>425</fpage>
            <page-range>425-33</page-range>
            <pub-id pub-id-type="pmid">11143909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahlm&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bjelle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prediction of team care effects in outpatients with rheumatoid arthritis.</article-title>
            <source>J Rheumatol</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>1655</fpage>
            <page-range>1655-61</page-range>
            <pub-id pub-id-type="pmid">1787485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deminger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klingberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Geijer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f6;thlin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hedberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rehnberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carlsten</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jacobsson</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Forsblad-d'Elia</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2018</year>
            <month>Aug</month>
            <day>03</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>162</fpage>
            <pub-id pub-id-type="pmid">30075808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28255.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kullich</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Neff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>P&#x000f6;llmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Machreich</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schwann</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Adhesion molecule ICAM-1 in patients with chronic polyarthritis--effects of inpatient rehabilitation].</article-title>
            <source>Wien Med Wochenschr</source>
            <year>1999</year>
            <volume>149</volume>
            <issue>19-20</issue>
            <fpage>550</fpage>
            <page-range>550-3</page-range>
            <pub-id pub-id-type="pmid">10637965</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
